Flu Season Alert!Alerta de temporada de influenza:
Don’t let germs win this season – protect yourself and your family!
The flu vaccine is your best defense against flu and related complications – PLUS, it is a covered benefit for Texas Children’s Health Plan members! Learn more!
¡No permitas que los gérmenes ganen esta temporada! ¡Protégete a ti y a tu familia!
La vacuna contra la influenza es tu mejor defensa contra la influenza y sus complicaciones. Además, ¡es un beneficio cubierto para los miembros de Texas Children's Health Plan! Aprende más
Change in PDL Status for the Immunomodulators, Atopic Dermatitis and Ophthalmics, Anti-Inflammatories Drug Classes
Date: April 7, 2025
Attention: Providers
Effective date: April 4, 2025
Call to action: Effective April 4, 2024, the Texas Health and Human Services (HHS) removed non-preferred status from generic pimecrolimus cream and loteprednol eye drop suspension. This is in response to a drug shortage of the preferred brand name product Elidel 1% cream (pimecrolimus) and drug discontinuation of the preferred name product Lotemax 0.5% Eye Drop suspension (loteprednol etabonate 0.5%).
How this impacts providers: The change will allow providers to prescribe the generic without requiring PDL prior authorization at this time and continue accessing necessary medication for their patients.
Next step for Providers: Prescribers are encouraged to proactively obtain a prescription for the preferred alternatives to avoid disruption in patient’s therapy. Prescribers should share this communication with their staff.
